The Europe diabetes care devices market size is expected to reach USD 15.11 billion by 2030, registering a CAGR of 7.0% during the forecast period. The size of the market is justified by the contribution from developed European economies such as Germany, U.K., France, and Italy. The prevalence of diabetes is rising amongst all ages in the European countries, mainly due to the unhealthy lifestyle, obesity, overweight, and physical inactivity. According to the International Diabetes Federation (IDF), around 66.0 million people in Europe are suffering from diabetes and this number is expected to increase to around 81.0 million by 2045. Thus, rising diabetes population base in this region is anticipated to be a major driver for the Europe diabetes devices market.
Additionally, the region is expected to witness high growth rate during the forecast period due to the continuous efforts towards diabetes control by the government and healthcare organizations such as the IDF. These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding in the region is anticipated to propel the market’s growth.
Moreover, rising geriatric population is also anticipated to propel the market growth over the forecast period. In 2018, nearly one fifth of the Europe’s population was over 65 years age which is further fueling the diabetes device market. According to the United Nation report on World Population Aging, older population in Europe is projected to constitute 35.0% of total population by 2050. Furthermore, leading manufacturers are focusing on technological innovations and advanced product development to gain remarkable share in the market.
This product will be delivered within 1-3 business days.
Additionally, the region is expected to witness high growth rate during the forecast period due to the continuous efforts towards diabetes control by the government and healthcare organizations such as the IDF. These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding in the region is anticipated to propel the market’s growth.
Moreover, rising geriatric population is also anticipated to propel the market growth over the forecast period. In 2018, nearly one fifth of the Europe’s population was over 65 years age which is further fueling the diabetes device market. According to the United Nation report on World Population Aging, older population in Europe is projected to constitute 35.0% of total population by 2050. Furthermore, leading manufacturers are focusing on technological innovations and advanced product development to gain remarkable share in the market.
Europe Diabetes Care Devices Market Report Highlights
- Germany diabetes care device market is expected to grow rapidly during the forecast period, owing to favorable reimbursement policies, local presence of key market players, and supportive government initiatives.
- Blood glucose monitoring (BGM) devices are expected to register significant growth over the forecast period, registering a CAGR of 6.5% over the forecast period.
- In 2023, Hospital pharmacies dominated the market and accounted for a share of 54.1%.
- Insulin pumps segment is expected to grow during the forecast period. The segment is primarily driven by its advantage such as need of fewer injections to deliver insulin.
The leading players in the Europe Diabetes Care Devices market include:
- Medtronic plc
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- LifeScan IP Holdings, LLC
- B. Braun Melsungen AG
- Dexcom, Inc.
- Insulet Corporation
- Ypsomed Holding AG
- Companion Medical, Inc.
- Sanofi S.A.
- Valeritas Holdings, Inc.
- Novo Nordisk A/S
- Arkray, Inc.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Diabetes Care Devices Market Variables, Trends, & Scope
Chapter 4. Europe Diabetes Care Devices Market: Product Estimates & Trend Analysis
Chapter 5. Europe Diabetes Care Devices Market: Distribution Channel Estimates & Trend Analysis
Chapter 6. Europe Diabetes Care Devices Market: End Use Estimates & Trend Analysis
Chapter 7. Europe Diabetes Care Devices Market: Country Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
The leading players in the Europe Diabetes Care Devices market include:- Medtronic plc
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- LifeScan IP Holdings, LLC
- B. Braun Melsungen AG
- Dexcom, Inc.
- Insulet Corporation
- Ypsomed Holding AG
- Companion Medical, Inc.
- Sanofi S.A.
- Valeritas Holdings, Inc.
- Novo Nordisk A/S
- Arkray, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 9.36 Billion |
| Forecasted Market Value ( USD | $ 15.11 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 15 |
